Lung Cancer
Lung Cancer Awareness Month: Potential new standard in NSCLC, immunotherapy timing matters
Lung Cancer Awareness Month, observed every November, is intended to educate the public about the potential causes and risk factors of the disease.
‘Troubling’ data show lack of awareness about lung cancer screening
Most people at high risk for lung cancer have not discussed screening for the disease with their clinician or have even heard of the test, according to a research letter published in JAMA Network Open.
Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release)
In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.
Cancer detection rates improved the second year of the pandemic, but deficits remained
Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.
‘More sensitive’ HER2 test may allow for more personalized lung cancer therapy
Researchers developed a highly sensitive, analytic, quantitative immunofluorescence assay that may enable more patients with lung cancer to benefit from an approved targeted therapy.
Person-centered language in oncology helps people ‘feel genuinely cared for’
When referring to individuals with cancer, emphasizing the person rather than the condition improves patient morale and refocuses clinicians on the mission of patient-centered care, according to an opinion paper published in JAMA Oncology.
‘Doc, I’m ready to quit’: Evidence-based approaches to smoking cessation
A 50-year-old man has been a patient in the practice for the past 25 years.
GOLD International COPD Conference to cover spirometry, treatments, multimorbidity
The 2024 GOLD International COPD Conference will be held Nov. 11 and 12 in Philadelphia and online, featuring presentations from various speakers on important topics pertaining to COPD care.
‘Real-life impact’: Early smoking cessation after cancer diagnosis maximizes survival benefit
Smoking cessation within 6 months of a cancer diagnosis can significantly improve survival, according to results of a prospective study.
Adjuvant durvalumab extends survival in limited-stage small cell lung cancer
Adjuvant durvalumab significantly improved PFS and OS compared with placebo among patients with limited-stage small cell lung cancer, according to study results presented at ESMO Congress.